[Therapeutic effect of fominoben in obstructive respiratory disorders and respiratory insufficiency].
D000402:Airway Obstruction / Q000188:drug therapy*; D000813:Anilides / Q000627:therapeutic use; D000996:Antitussive Agents / Q000627:therapeutic use*; D001784:Blood Gas Analysis; D002245:Carbon Dioxide / Q000097:blood; D002986:Clinical Trials as Topic; D003371:Cough / Q000188:drug therapy; D006801:Humans; D008744:Methylamines / Q000627:therapeutic use; D009025:Morpholines / Q000627:therapeutic use*; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D011653:Pulmonary Diffusing Capacity / Q000187:drug effects; D012126:Respiratory Dead Space / Q000187:drug effects; D012131:Respiratory Insufficiency / Q000188:drug therapy*; D014692:Ventilation-Perfusion Ratio / Q000187:drug effects
D000813:Anilides; D000996:Antitussive Agents; D008744:Methylamines; D009025:Morpholines; D002245:Carbon Dioxide; D010100:Oxygen
atemtherapeutische Wirkung von Fominoben bei obstrucktiver Ventilationsstörung und respiratorischer Insuffizienz.